Abstract
In an epidemiologic and case-control study including 30 case patients over a 3.5-year period in a Taiwanese university hospital, only β-lactamase inhibitor use and extended-spectrum cephalosporin use were identified as independent risk factors for nosocomial CMY-2-producing Escherichia coli bloodstream infection, and CMY-2 producers were found more prevalent than extended-spectrum β-lactamase-producing isolates.
Original language | English |
---|---|
Pages (from-to) | 3329-3332 |
Number of pages | 4 |
Journal | Journal of Clinical Microbiology |
Volume | 42 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2004 Jul |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)